Position in SNDX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,284,414
-$1,396,709 QoQ
Shares Held
241,739
-15.5% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
#68
of 240 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTOR GAMMA AS holds $108,300,814 across 14 Biotechnology names. SNDX ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
170,753 | $19,356,560 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
294,918 | $16,875,207 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
189,468 | $15,022,917 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,780 | $9,839,461 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
100,000 | $8,157,000 | |
| 6 | ASND |
Ascendis Pharma A/S
|
21,305 | $5,682,469 | |
| 7 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
241,739 | $5,284,414 | |
| 8 | KURA |
Kura Oncology, Inc.
|
433,012 | $4,750,141 |
All Filings in SNDX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,284,414 | 241,739 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,681,123 | 286,007 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,295,822 | 252,062 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,243,373 | 210,814 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||